Xin‐Bin Pan

机构：Guangxi Medical University, Tumor Hospital of Guangxi Medical University · ORCID：0000-0002-6765-6587

发表论文 63 篇 · 总被引 401 次 · h-index 13

代表论文

Nivolumab adjuvant therapy for esophageal cancer: a review based on subgroup analysis of CheckMate 577 trial (2023 · Frontiers in Immunology · 被引 17)
Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis (2023 · Aging · 被引 13)
Immune checkpoint inhibitors combined with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (2024 · Frontiers in Immunology · 被引 4)
Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma (2024 · BMC Cancer · 被引 4)
Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer (2024 · Scientific Reports · 被引 3)
Lobectomy versus sublobar resection on survival in patients with stage T1-2N0M0 small cell lung cancer (2025 · PLoS ONE · 被引 2)